Hong Kong Stock Movements | Meike Medical-B (02335.HK) rises over 3% as MT200605 preclinical and Phase I clinical data accepted for oral presentation at the WSC 2026 conference.

According to Zhithong Finance APP, Maike Pharmaceuticals-B (02335.HK) has risen over 3%. As of the time of writing, it has increased by 3.17%, priced at HKD 29.94, with a transaction volume of HKD 6.3033 million.